- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Well-Grounded With Room To Grow
Global Pharmaceuticals & Biotech Well-Grounded With Room To Grow
UPDATED Nov 27, 2023
Financially strong companies with expected earnings growth in the next 3 years.
41 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| TECNTecan Group | CHF309.40 | 2.0% | -24.1% | CHF4.0b | CHF435.00 | PE36.4x | E14.5% | 0.9% | ||
| MEDPMedpace Holdings | US$275.92 | -0.02% | 29.8% | US$8.5b | US$278.60 | PE31x | E14.6% | n/a | ||
| A214450PharmaResearch | â‚©110,100.00 | -4.9% | 72.6% | â‚©1.1t | â‚©165,000.00 | PE20.2x | E24.9% | 0.6% | ||
| 2262Jiangsu Nhwa Pharmaceutical | CNÂ¥25.55 | -0.2% | 34.2% | CNÂ¥25.7b | CNÂ¥31.34 | PE24.6x | E20.5% | 0.8% | ||
| 739Apeloa PharmaceuticalLtd | CNÂ¥16.61 | -0.5% | -20.3% | CNÂ¥19.4b | CNÂ¥23.46 | PE16.4x | E20.9% | 1.8% | ||
| NEUNeuren Pharmaceuticals | AU$14.86 | 0.7% | 76.9% | AU$1.9b | AU$20.15 | PE34.2x | E4.2% | n/a | ||
| APLLTDAlembic Pharmaceuticals | ₹725.45 | -3.2% | 20.9% | ₹142.6b | ₹742.44 | PE26.8x | E18.1% | 1.1% | ||
| ALK BALK-Abelló | kr.91.60 | -3.1% | -8.5% | kr.20.3b | kr.110.50 | PE47.8x | E39.4% | 0% | ||
| LONNLonza Group | CHF344.80 | -3.5% | -31.1% | CHF25.6b | CHF516.89 | PE22.7x | E9.5% | 1.0% | ||
| 2675Yantai Dongcheng Pharmaceutical GroupLtd | CNÂ¥17.98 | -1.2% | 7.3% | CNÂ¥14.8b | CNÂ¥20.30 | PE56.4x | E30.5% | 0.8% | ||
| SFZNSiegfried Holding | CHF786.00 | -0.1% | 22.1% | CHF3.3b | CHF881.88 | PE22.4x | E10.5% | 0.4% | ||
| A000100Yuhan | â‚©61,900.00 | -0.5% | 14.2% | â‚©4.4t | â‚©86,444.44 | PE51.1x | E36.0% | 0.6% | ||
| GLSGlenmark Life Sciences | ₹634.80 | 1.5% | 47.1% | ₹77.8b | ₹685.00 | PE15.4x | E11.7% | 3.5% | ||
| 600557Jiangsu Kanion PharmaceuticalLtd | CNÂ¥18.93 | 3.7% | -23.9% | CNÂ¥11.1b | CNÂ¥23.60 | PE22x | E20.8% | 1.2% | ||
| 603259WuXi AppTec | CNÂ¥83.13 | -4.3% | 9.3% | CNÂ¥247.6b | CNÂ¥121.24 | PE25.9x | E21.0% | 1.1% | ||
| NATCOPHARMNATCO Pharma | ₹780.45 | -0.06% | 37.6% | ₹139.8b | ₹812.25 | PE12.4x | E13.9% | 0.7% | ||
| PNTPOINT Biopharma Global | US$13.80 | 0.7% | 109.4% | US$1.5b | US$15.55 | PE15.2x | E2.7% | n/a |